Nottingham University Hospitals NHS Trust - City Hospital | ClinicalTrials HQ

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy	Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, kidney disorder, urinary system disorder	Recruiting	Phase 3	2026-09-30		NCT06963827
Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification	Choroid Plexus Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, brain disorder, capillary hemangioma, central nervous system cancer, central nervous system disorder, central nervous system melanocytic neoplasm, cerebral ventricle cancer, diffuse midline glioma, H3 K27M-mutant, embryonal neoplasm, ependymoma, epithelial neoplasm, glioma, hemangioblastoma, hemangioma, hemangiopericytoma, neoplasm, nervous system disorder, neuroepithelial neoplasm, pineal body neoplasm, primitive neuroectodermal tumor, vascular cancer	Recruiting	Not stated	2025-12-17		NCT05259605
Phase III Radium 223 mCRPC-PEACE III	Genital Diseases, Male Urogenital Diseases, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Phase 3	2025-09-19		NCT02194842